Short Courses and Special Courses
SC44 - Shedding Light on the “Gray Zones” of Neoplastic Lung Pathology
Wednesday, March 21, 2018 - 1:30 pm - 5:30 pm
This Short Course session includes up to one-hour break time.
3 CME and 3 SAMs
Lynette Sholl, MD, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
Sanja Dacic MD, PhD, University of Pittsburgh, Pittsburgh, PA
Marina Vivero, MD, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
Rapid advances in the field of molecular diagnostics and imaging have led to dramatic shifts in diagnosis and clinical management of lung cancers. This course is designed for general surgical pathologists and pathologists-in-training. We will emphasize the diagnostic interpretation of biopsy and resection specimens obtained for management of neoplastic lung diseases, focusing on problematic and controversial concepts.
Using a series of case presentations, this course on tumor types whose classifications have shifted over time, creating confusion for pathologists and oncologists alike. We will focus on the histopathologic, immunohistochemical, and molecular characterization of in situ and invasive adenocarcinoma, large cell carcinoma, pulmonary vascular tumors, and neuroendocrine tumors. Special emphasis will be placed on some of the unique challenges in pulmonary pathology, including changes to the staging systems, drawing distinctions between multiple primaries vs. metastases, and use of immunohistochemistry for diagnosis of small biopsies. This course will focus on classifications and staging in flux, entities that create confusion for oncologists, and tumors with unpredictable biologic behavior.
Upon completion of this educational activity, the learner will be able to:
- Identify the appropriate usage of immunohistochemistry in the diagnosis of thoracic neoplasms;
- Identify the appropriate usage of molecular techniques in the diagnosis and management of thoracic neoplasms;
- Become familiar with current classification schema with an emphasis on those entities that have undergone significant revision.
Continuing Medical Education and Maintenance of Certification
The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The United States and Canadian Academy of Pathology designates this live activity for a maximum of 3 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The USCAP is approved by the American Board of Pathology (ABP) to offer Self-Assessment credits (SAMs) for the purpose of meeting the ABP requirements for Maintenance of Certification (MOC). Physicians must take and pass the post-test in order to claim SAMs credit.
Physicians can earn a maximum of 3 SAM credit hours.
Return to 2018 Annual Meeting Short Course Page